Statistics
Publications
13
Citations
1.4K
H-Index
12
Active since
2001
Suliman Al‐Fayoumi is an author at CTI BioPharma (United States) specializing in pharmacology, medicine, and jak inhibitors.
Publications per year
2001–2019
13
13
Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis
John Mascarenhas, Ronald Hoffman, Moshe Talpaz et al. · JAMA Oncology · 2018 · 380 citations · Full text
Medicine, Hematology, Pharmacology +13
1–5 of 13